AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 18 filers reported holding AKARI THERAPEUTICS PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,115,000 | -17.3% | 158,352 | 0.0% | 1.20% | -9.6% |
| Q3 2016 | $1,348,000 | -36.9% | 158,352 | 0.0% | 1.33% | -40.1% |
| Q2 2016 | $2,136,000 | -3.7% | 158,352 | 0.0% | 2.21% | +15.0% |
| Q1 2016 | $2,217,000 | -3.4% | 158,352 | 0.0% | 1.92% | +38.7% |
| Q4 2015 | $2,296,000 | -81.9% | 158,352 | -70.0% | 1.39% | -57.3% |
| Q3 2015 | $12,666,000 | – | 527,842 | – | 3.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,000 | $543 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Truvestments Capital LLC | 1,005 | $183 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |